Diagnostic evaluation of the irritable bowel syndrome
- PMID: 2066152
Diagnostic evaluation of the irritable bowel syndrome
Abstract
New, restrictive criteria discriminate the irritable bowel syndrome (IBS) from normals and other gastrointestinal disorders with a high degree of specificity but lesser sensitivity. The diagnosis is based on positive features that include these criteria. In addition, some structural or biochemical disorders are ruled out by routine tests, whereas others require specialized tests when specific symptoms indicate. Extracolonic and extraintestinal symptoms that often accompany IBS suggest a generalized smooth-muscle or autonomic disorder that may require further investigation as well.
Similar articles
-
The irritable bowel syndrome: diagnostic strategies.Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):41-7. Ital J Gastroenterol. 1991. PMID: 1756282 Review.
-
Evaluation of Manning's criteria in the diagnosis of irritable bowel syndrome.J Assoc Physicians India. 1993 Jun;41(6):357-8, 363. J Assoc Physicians India. 1993. PMID: 8005973
-
Functional diagnostic work-up in patients with irritable bowel syndrome.Z Gastroenterol. 1996 May;34(5):273-8. Z Gastroenterol. 1996. PMID: 8686358
-
Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria.Am J Gastroenterol. 1999 May;94(5):1279-82. doi: 10.1111/j.1572-0241.1999.01077.x. Am J Gastroenterol. 1999. PMID: 10235207
-
Motility disorders in the irritable bowel syndrome.Gastroenterol Clin North Am. 1991 Jun;20(2):279-95. Gastroenterol Clin North Am. 1991. PMID: 2066153 Review.
Cited by
-
Metabolomics in Central Sensitivity Syndromes.Metabolites. 2020 Apr 24;10(4):164. doi: 10.3390/metabo10040164. Metabolites. 2020. PMID: 32344505 Free PMC article. Review.
-
Computerized auscultation applied to irritable bowel syndrome.Dig Dis Sci. 1999 Sep;44(9):1887-92. doi: 10.1023/a:1018859110022. Dig Dis Sci. 1999. PMID: 10505730 Clinical Trial.
-
Quality of life in irritable bowel syndrome.Pharmacoeconomics. 2001;19(6):643-53. doi: 10.2165/00019053-200119060-00003. Pharmacoeconomics. 2001. PMID: 11456212 Review.
-
An antiemetic for irritable bowel syndrome?J Fam Pract. 2014 Oct;63(10):600-2. J Fam Pract. 2014. PMID: 25343149 Free PMC article.
-
Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial.Middle East J Dig Dis. 2017 Jan;9(1):20-25. doi: 10.15171/mejdd.2016.47. Middle East J Dig Dis. 2017. PMID: 28316762 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical